Effect of Mad2 on paclitaxel-induced cell death in ovarian cancer cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 30, Issue 5, 2010, Pages 620-625

  Hao, Xing ^a   Zhou, Zhigang ^b   Ye, Shuangmei ^a   Zhou, Ting ^a   Lu, Yunping ^a   Ma, Ding ^a   Wang, Shixuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Hubei Provincial Maternal and Children's Hospital   (China)

Author keywords

Bcl 2; Mad2; ovarian cancer; paclitaxel resistance

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM BINDING PROTEIN; CELL CYCLE PROTEIN; MAD2L1 PROTEIN, HUMAN; ONCOPROTEIN; PACLITAXEL; PROTEIN BCL 2; REPRESSOR PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CELL DEATH; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; OVARIAN NEOPLASMS; PACLITAXEL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS; RNA, SMALL INTERFERING;

EID: 78649849296     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-010-0553-y     Document Type: Article

References (25)

1. E.K. Rowinsky 1997 The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents Annu Rev Med 48 353 374 1:CAS:528:DyaK2sXhtFOmsLs%3D 10.1146/annurev.med.48.1.353 9046968 (Pubitemid 27101837)
2. J. Kovár M. Ehrlichová B. Smejkalová, et al. 2009 Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells Anticancer Res 29 8 2951 2960 19661300
3. E.K. Rowinsky R.C. Donehower 1995 Paclitaxel New Engl J Med 332 15 1004 1014 1:STN:280:DyaK2M7ptFKisg%3D%3D 10.1056/NEJM199504133321507 7885406
4. E. Winey B.J. Huneycutt 2002 Centrosomes and checkpoints: the MPS1 family of kinases Oncogene 21 40 6161 6169 1:CAS:528:DC%2BD38Xms1ykurk%3D 10.1038/sj.onc.1205712 12214245
5. F.A. Fisk M. Winey 2004 Mps1 flies into new areas Curr Biol 14 24 R1058 R1060 1:CAS:528:DC%2BD2cXhtFGhtbzO 10.1016/j.cub.2004.11.047 15620641 (Pubitemid 40033351)
6. J. Zhou J. Yao H.C. Joshi 2002 Attachment and tension in the spindle assembly checkpoint J Cell Sci 115 18 3547 3555 1:CAS:528:DC%2BD38XnvFGns7w%3D 10.1242/jcs.00029 12186941
7. D.J. Burke P.T. Stukenberg 2008 Linking kinetochore-microtubule binding to the spindle checkpoint Dev Cell 14 4 474 479 1:CAS:528:DC%2BD1cXltFOisbc%3D 10.1016/j.devcel.2008.03.015 18410725 (Pubitemid 351479945)
8. M.V. Blagosklonny T. Fojo 1999 Molecular effects of paclitaxel: myths and reality (a critical review) Int J Cancer 83 2 151 156 1:CAS:528: DyaK1MXmvVers7s%3D 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3. 0.CO;2-5 10471519 (Pubitemid 29449089)
9. P. Singh K. Rathinasamy R. Mohan, et al. 2008 Microtubule assembly dynamics: an attractive target for anticancer drugs IUBMB Life 60 6 368 375 1:CAS:528:DC%2BD1cXhtlKnu7rE 10.1002/iub.42 18384115
10. T. Takahashi N. Haruki S. Nomoto 1999 Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC in human lung cancers Oncogene 18 30 4295 4300 1:CAS:528:DyaK1MXlt1entbs%3D 10.1038/sj.onc.1202807 10439037 (Pubitemid 29392370)
11. X. Wang D.Y. Jin Y.C. Wong, et al. 2000 Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells Carcinogenesis 21 12 2293 2297 1:CAS:528:DC%2BD3MXmsFyrtA%3D%3D 10.1093/carcin/21.12.2293 11133821
12. X. Wang D.Y. Jin R.W. Ng, et al. 2002 Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells Cancer Res 62 6 1662 1668 1:CAS:528:DC%2BD38XisVSisLY%3D 11912137
13. B.T. McGrogan B. Gilmartin D.N. Carney, et al. 2008 Taxanes, microtubules and chemoresistant breast cancer Biochim Biophys Acta 1785 2 96 132 1:CAS:528:DC%2BD1cXkvFWlu78%3D 18068131
14. A. González Martín 2009 Anti-angiogenic therapy in ovarian cancer: a great expectation to be confirmed Clin Transl Oncol 11 9 559 560 10.1007/s12094-009-0404-0 19775993
15. A. Jemal T. Murray A. Samuels, et al. 2003 Cancer statistics CA Cancer J Clin 53 1 5 26 10.3322/canjclin.53.1.5 12568441
16. A. Richardson S.B. Kaye 2005 Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance Drug Resist Updat 8 5 311 321 1:CAS:528:DC%2BD2MXht1Oms7%2FF 10.1016/j.drup.2005.09.001 16233989 (Pubitemid 41677714)
17. H.Y. Yamada G.J. Gorbsky 2006 Spindle checkpoint function and cellular sensitivity to antimitotic drugs Mol Cancer Ther 5 12 2963 2969 1:CAS:528:DC%2BD28Xhtlagsb3O 10.1158/1535-7163.MCT-06-0319 17172401 (Pubitemid 46092037)
18. N. Malmanche A. Maia E.S. Claudio 2006 The spindle assembly checkpoint: Preventing chromosome mis-segregation during mitosis and meiosis FEBS Letters 580 12 2888 2895 1:CAS:528:DC%2BD28XltVKnt7k%3D 10.1016/j.febslet.2006.03.081 16631173 (Pubitemid 43729177)
19. T. Zhou Y. Bao S. Ye, et al. 2010 Effect of spindle checkpoint on Akt2-mediated paclitaxel-resistance in A2780 ovarian cancer cells J Huazhong Univ Sci Technolog [Med Sci] 30 2 206 11 1:CAS:528:DC%2BC3cXltVWksbw%3D 10.1007/s11596-010-0215-0
20. G.J. Gorbsky R.H. Chen A.W. Murray 1998 Microinjection of antibody to Mad2 protein into mammalian cells in mitosis induces premature anaphase J Cell Biol 141 5 1193 1205 1:CAS:528:DyaK1cXjs12ntLY%3D 10.1083/jcb.141.5.1193 9606211 (Pubitemid 28265613)
21. T. Sudo M. Nitta H. Saya, et al. 2004 Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint Cancer Res 64 7 2502 2508 1:CAS:528:DC%2BD2cXis1yjtbc%3D 10.1158/0008-5472.CAN-03-2013 15059905 (Pubitemid 38523906)
22. E.A. Lee M.K. Keutmann M.L. Dowling, et al. 2004 Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells Mol Cancer Ther 3 6 661 669 1:CAS:528:DC%2BD2cXltVajsrw%3D 15210851
23. R.K. Srivastava Q.S. Mi J.M. Hardwick, et al. 1999 Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis Proc Natl Acad Sci USA 96 7 3775 80 1:CAS:528:DyaK1MXjslChsrw%3D 10.1073/pnas.96.7.3775 10097113 (Pubitemid 29168986)
24. K.G. Wolter S.J. Wang B.S. Henson, et al. 2006 (-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo Neoplasia 8 3 163 172 1:CAS:528:DC%2BD28XovVKlurw%3D 10.1593/neo.05691 16611409 (Pubitemid 43671231)
25. N.J. Mackler K.J. Pienta 2005 Drug insight: Use of docetaxel in prostate and urothelial cancers Nat Clin Pract Urol 2 2 92 100 1:CAS:528: DC%2BD2MXjsFaksrk%3D 10.1038/ncpuro0099 16474654 (Pubitemid 40790129)